DekaBank Deutsche Girozentrale
ICPT

DekaBank Deutsche Girozentrale’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,090
Closed -$167K – 1502
2021
Q3 		$167K Hold
11,090
– – ﹤0.01% 1236
2021
Q2 		$230K Hold
11,090
– – ﹤0.01% 1194
2021
Q1 		$248K Hold
11,090
– – ﹤0.01% 1147
2020
Q4 		$270K Hold
11,090
– – ﹤0.01% 1137
2020
Q3 		$457K Buy
+11,090
New +$510K ﹤0.01% 950
2019
Q4 		– Sell
-14,240
Closed -$913K – 1237
2019
Q3 		$913K Sell
14,240
-15,140
-52% -$1.02M 0.01% 686
2019
Q2 		$2.33M Buy
29,380
+21,390
+268% +$1.91M 0.01% 589
2019
Q1 		$878K Sell
7,990
-6,700
-46% -$732K 0.01% 800
2018
Q4 		$1.37M Buy
14,690
+6,700
+84% +$694K 0.01% 613
2018
Q3 		$878K Sell
7,990
-200
-2% -$21.2K 0.01% 817
2018
Q2 		$654K Hold
8,190
– – ﹤0.01% 846
2018
Q1 		$493K Sell
8,190
-200
-2% -$12.1K ﹤0.01% 873
2017
Q4 		$885K Hold
8,390
– – 0.01% 716
2017
Q3 		$885K Hold
8,390
– – 0.01% 724
2017
Q2 		$1.03M Hold
8,390
– – 0.01% 687
2017
Q1 		$947K Buy
8,390
+5,800
+224% +$677K 0.01% 624
2016
Q4 		$294K Buy
2,590
+200
+8% +$23.8K ﹤0.01% 762
2016
Q3 		$383K Hold
2,390
– – ﹤0.01% 716
2016
Q2 		$358K Sell
2,390
-8,080
-77% -$1.18M ﹤0.01% 747
2016
Q1 		$1.31M Sell
10,470
-1,840
-15% -$217K 0.02% 511
2015
Q4 		$1.85M Buy
12,310
+200
+2% +$33.9K 0.02% 472
2015
Q3 		$2.01M Buy
12,110
+1,200
+11% +$264K 0.02% 451
2015
Q2 		$2.63M Buy
10,910
+400
+4% +$107K 0.03% 402
2015
Q1 		$2.96M Buy
+10,510
New +$2.28M 0.04% 387

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ICPT Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 11,090 shares — an estimated $167K sold.

DekaBank Deutsche Girozentrale first reported a position in ICPT in Q1 2015 and held it in 24 quarters. The position peaked at $2.96M in Q1 2015. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 11,090 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $167K.
  • DekaBank Deutsche Girozentrale first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 24 quarters.
  • DekaBank Deutsche Girozentrale's Intercept Pharmaceuticals, Inc. position peaked at $2.96M in Q1 2015.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.